Thema
prev ...
Clinical Trial, Phase II
3
Conserved protein
3
Hemagglutinins
3
IgG
3
Immune response
3
Immunogenicity
3
Infections
3
Influenza M2 ectodomain
3
Influenza a virus
3
Influenza virus
3
Intranasal Administration
3
Live Attenuate Influenza Vaccine
3
M2e antigen
3
Madin Darby Canine Kidney Cell
3
Mutation
3
Nucleoproteins
3
Placebos
3
Spike Glycoprotein, Coronavirus
3
Syrian hamsters
3
cross-reactivity
3
humoral immunity
3
influenza vaccine
3
influenza virus
3
mouse model
3
nucleoprotein
3
pandemic influenza
3
recombinant influenza virus
3
recombinant protein
3
spike protein, SARS-CoV-2
3
500
2
789U1901C5
2
82115-62-6
2
A/H1N1
2
A/H5N2
2
Adjuvants, Immunologic
2
Anti-neuraminidase antibodies
2
Antibodies
2
Antigens, Viral
2
Avian flu
2
Biological sciences
2
Biology
2
Bivalent vaccine
2
COVID-19 convalescents
2
COVID-19 vaccine
2
Clinical trial
2
Clinical trials
2
Comment
2
Copper
2
Disease control
2
EC 2.7.7.48
2
mehr ...